IPG Photonics Corporation — Q3 2020 Form 10-Q
Reporting period: Quarter and nine months ended September 30, 2020. Financial statements are unaudited; amounts below are in U.S. dollars. IPG develops and sells fiber lasers, amplifiers, diode lasers, and related systems, primarily for materials processing.
Financial performance
| Metric | Q3 2020 | Q3 2019 | Nine months 2020 | Nine months 2019 |
|---|---|---|---|---|
| Net sales | $318.4m | $329.1m | $864.1m | $1,008.0m |
| Gross profit / margin | $152.8m / 48.0% | $152.9m / 46.4% | $392.1m / 45.4% | $482.0m / 47.8% |
| Operating income | $41.4m | $74.1m | $133.4m | $233.6m |
| Net income attributable to IPG | $35.6m | $57.3m | $110.2m | $184.7m |
| Diluted EPS | $0.66 | $1.07 | $2.05 | $3.43 |
| Operating cash flow | Not provided for quarter | Not provided for quarter | $200.0m | $193.6m |
- Q3 sales fell 3.3% year over year; nine-month sales fell 14.3%. Materials-processing sales declined 5.3% in Q3 and 18.2% year to date. Other applications grew 24.2% in Q3 and 53.2% year to date.
- Q3 gross margin improved, mainly due to lower product costs, partly offset by higher inventory provisions. Nine-month margin declined, reflecting lower average selling prices and under-absorbed manufacturing costs.
- Q3 included a $44.6m non-cash goodwill impairment for the Genesis custom systems business. A $11.3m foreign-exchange gain partly offset operating pressures. Nine-month foreign-exchange gain was $18.1m.
- Nine-month investing cash outflow was $96.1m, including $61.9m of capital expenditures; financing cash outflow was $25.6m. Cash, cash equivalents and restricted cash totaled $766.1m at September 30.
Balance sheet and liquidity
- Cash and cash equivalents were $763.9m and short-term investments were $537.7m at September 30, versus $680.1m and $502.5m, respectively, at December 31, 2019.
- Total debt was $38.9m, including $3.8m current debt. No amounts were drawn on revolving credit facilities; available unused lines and overdraft facilities totaled $129.0m. IPG reported compliance with debt covenants.
- Total assets were $2.795bn and total equity was $2.471bn. Inventory was $370.3m, down from $380.8m at year-end.
Changes, outlook, and risks
- COVID-19 reduced demand in several regions and markets, particularly North America, Europe, and Japan; China sales showed improvement. Management said forecasting remained difficult and could not reasonably estimate the pandemic’s future financial impact.
- Management expected COVID-19 to adversely affect revenue, profitability, and operating cash flow, with potential added inventory and credit-loss provisions and possible further asset impairments. Facilities were operating, but safety measures affected productivity; renewed restrictions, absenteeism, or logistics constraints could disrupt operations.
- Management expected 2020 capital expenditures of $80m–$100m, excluding acquisitions, and believed existing liquidity, expected operating cash flows, and credit availability were sufficient for requirements over the next 12 months. Spending, acquisitions, and repurchases could be adjusted for conditions.
- One customer represented 35% of accounts receivable at September 30. Competition and lower selling prices, cyclical capital-equipment spending, foreign-exchange volatility, and dependence on internally sourced components are material risks.
- IPG repurchased $37.9m of stock in the first nine months. The Board had authorized an additional $200m repurchase program in May; the authorization does not require purchases. On October 1, IPG acquired Brazil-based Pi-Tecnologia for $2.7m, partly contingent on future financial targets.
- Management reported no legal proceedings expected to materially affect the financial statements. The filing disclosed no material change in internal control over financial reporting.
Key facts for investors to verify
- Whether demand recovery, particularly in China, offsets continued weakness in other markets and lower average selling prices.
- Whether inventory provisions, fixed-cost absorption, and the Genesis business create further margin pressure or impairment charges.
- Cash generation and working-capital needs under continued pandemic uncertainty, alongside planned capital spending and share repurchases.
- Customer concentration and foreign-exchange exposures, including the disclosed sensitivity to 5% currency movements.
- Actual 2020 capital expenditures relative to the $80m–$100m expectation and the terms and performance milestones for the Pi-Tecnologia acquisition.